Syndrome in Biological Technology

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

... on target for launches thereafter. Down syndrome Test - The company is evaluating both RNA and DNA approaches for a Down syndrome test, and it is taking a rigorous and detailed ... journals prior to the launch of any Down syndrome test that the company develops. ...

Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome

... symptoms associated with carcinoid syndrome . LX1032 is designed to reduce serotonin ... symptoms experienced by patients with carcinoid syndrome who have become refractory to current treatment ... will include up to 28 patients with carcinoid syndrome who are symptomatic despite treatment with ...

Publication of Shire plc's Annual Report 2008

... from Zymenex. HGT-2310 - Hunter syndrome with central nervous system ... -formerly referred to as ELAPRASE for Hunter syndrome patients with significant central nervous system ... quarter of 2009. HGT-1410 for Sanfilippo syndrome (Mucopolysaccharidosis IIIA) HGT-1410 is ...

Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial

... to patients within 96 hours of an Acute Coronary syndrome (ACS) event. "We are pleased with the ... of inflammation. About Acute Coronary syndrome Acute coronary syndrome is a heart condition characterized by chest ...

$1.6 Million Agreement to Accelerate Fragile X Research, Inspire Hope

... and improve treatments for fragile X syndrome will be funded by a new $1.6 million, three-year ... Center at Columbia University. Fragile X syndrome is the most common known cause of ... such as fragile X-associated tremor/ataxia syndrome and fragile X-associated primary ovarian ...

AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women

... prescription medication for Irritable Bowel syndrome with Constipation BETHESDA, Md., and DEERFIELD, ... the U.S. for the treatment of Irritable Bowel syndrome with Constipation (IBS-C) in women 18 years and ... North America, Inc. About Irritable Bowel syndrome with Constipation (IBS-C) IBS is a disorder ...

Novagali Pharma Announces the Launch of Cationorm(R)

... technology platform Novasorb(R). Dry eye syndrome is the second cause of consultation in ... to an increase in the prevalence of the syndrome and in opportunities for the development of more ... for the treatment of moderate-to-severe dry eye syndrome and Cortiject(R) for the treatment of diabetic ...

NPS Pharmaceuticals Reports 2007 Financial Results

... of GATTEX(TM) (teduglutide) in short bowel syndrome (SBS) patients who are dependent on parenteral ... study of GATTEX in patients with short bowel syndrome support our plans to initiate a confirmatory ... intestinal failure associated with short bowel syndrome and NPSP558 (parathyroid hormone 1-84 [rDNA ...

JCI online early table of contents: March 6, 2008

... HEMATOLOGY: Protein mutated in Shwachman-Diamond syndrome provides stability Shwachman-Diamond syndrome (SDS) is an inherited disorder, caused by genetic ... and genomic instability in Shwachman-Diamond syndrome AUTHOR CONTACT: Akiko Shimamura University ...

Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome

... milestone because for the first time, Hunter syndrome patients in Mexico have access to treatment," ... neglected diseases around the world." "Hunter syndrome is a devastating disease and until now, ... health data among individuals affected by Hunter syndrome as part of the company's long-term outcome ...

Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug

... marketing, and manufacture of a Dry Eye syndrome product. The product consists of a TRB patented ... bring significant relief to patients with Dry Eye syndrome and look forward to completing our clinical study ... agreement, to bringing to the USA Dry Eye syndrome patients our high-value eye drop therapy based on ...

Amarin Announces Initiation of Cardiovascular Development Strategy

... portfolio for the treatment of metabolic syndrome and dyslipidemia. Further information on dyslipidemia and metabolic syndrome is included later in this press release. Amarin ... vascular disease, metabolic syndrome (a component of which is dyslipidemia), ischaemic ...

Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome

... in bringing this much-needed treatment to Hunter syndrome patients around the world," said Sylvie Gregoire, ... health data among individuals affected by Hunter syndrome as part of the company's long-term outcome ... will allow for better understanding of Hunter syndrome and disease education on a global scale. More ...

FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)

... Increase Appropriate Early Use in Acute Coronary syndrome Patients - ... loading dose for appropriate acute coronary syndrome (ACS) patients as soon as possible after hospital ... and other vascular death. -- Acute Coronary syndrome (ACS) For patients with non-ST-segment ...

Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome

... principle trial for the treatment of fibromyalgia syndrome (FMS). The trial, a multi-centre, randomised, ... . About Fibromyalgia Fibromyalgia syndrome predominantly affects women between the ages ... disturbance and depression. The aetiology of the syndrome is not well understood but serotonin (5-HT) and ...

FDA Accepts Sucampo's sNDA for Lubiprostone (8 mcg) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

... daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for ... 58 million Americans have irritable bowel syndrome (IBS), with IBS-C accounting for approximately ... (4% vs. 5%, respectively). About Irritable Bowel syndrome with Constipation (IBS-C) IBS is a chronic ...

New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome

... Coronary Artery Disease (CAD) and Acute Coronary syndrome (ACS) Coronary artery disease (CAD) is the most ... an acute heart attack. Acute coronary syndrome (ACS) is an umbrella term used to describe ... unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J. 2007 ...

Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients

... and, rarely, hemolysis. Aseptic meningitis syndrome (AMS) has been reported to occur infrequently in ... disease (CJD) agent. Aseptic meningitis syndrome (AMS) has been reported to occur infrequently in ... disease (CJD) agent. Aseptic meningitis syndrome (AMS) has been reported to occur infrequently in ...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

... was the co-primary endpoint. The incidence of ovarian hyperstimulation syndrome (OHSS) was similar between both groups, 7.0 percent in the corifollitropin ... with corifollitropin alfa in clinical trials are Ovarian Hyperstimulation syndrome (OHSS), pelvic pain and discomfort, headache, nausea, fatigue and breast ...

Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply

... should be based on the potential benefits and risks; if Guillain-Barre syndrome has occurred within 6 weeks of receipt of a prior vaccine containing ... should be based on the potential benefits and risks; if Guillain-Barre syndrome has occurred within 6 weeks of receipt of a prior vaccine containing ...

Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk

... veins, venous leg ulcers, facial veins, hand veins, Klippel-Trenaunay syndrome and Restless Legs syndrome resulting from venous reflux. VCA is a wholly-owned subsidiary of ...

Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week

... LX1031 , an oral drug candidate for the treatment of irritable bowel syndrome (IBS), and LX1032 , an oral drug candidate for managing gastrointestinal symptoms associated with carcinoid syndrome . The presentations will take place at Digestive Disease Week (DDW) in ...

VAP(R) Cholesterol Test Now Available at ANY LAB TEST NOW(R)

... of $79 and also include it as part of two Value Panels, the Metabolic syndrome Panel ($229) and the Heart Health Panel ($279). The Metabolic syndrome Panel also includes a Chemistry Panel with 16 essential tests, Hemoglobin ...

Evoke Pharma, Inc. Initiates Phase 2b Metoclopramide Intranasal Trial (MINT) in Patients With Diabetic Gastroparesis

... of adults with symptoms of diabetic gastroparesis. Gastroparesis is a syndrome characterized by delayed emptying of the stomach into the intestine ... is a common GI problem affecting approximately 8 million Americans. The syndrome refers to delayed gastric emptying, in the absence of mechanical ...

Ecologists propose first prevention for white-nose syndrome death in bats

... White-nose syndrome (WNS) is a poorly understood condition that, in the two years since its ... this week in Frontiers in Ecology and the Environment e-View. The syndrome has baffled scientists since its discovery in the winter of 2006 in ...

European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI

... Feb. 23 /PRNewswire-FirstCall/ -- Heart patients with acute coronary syndrome (ACS) undergoing an artery-opening procedure will soon have a new ... undergoing PCI. About Acute Coronary Sy n drome Acute coronary syndrome includes heart attacks and unstable angina (chest pain). Coronary heart ...

Telik Implements Reorganization to Focus Resources Toward Drug Development Pipeline

... lead compound, TELINTRA, currently in Phase 2 Studies for Myleodysplastic syndrome and Chemotherapy Induced Neutropenia, as well as other potential ... glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA(R), a tumor-activated prodrug for the ...

Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University

... the diagnosis of fetal genetic disorders such as Down's syndrome, Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13). In parallel with this agreement, Artemis has extended its ...

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes

... deviations over 50 prism diopters, in restrictive strabismus, in Duane's syndrome with lateral rectus weakness, and in secondary strabismus caused by prior ... neuromuscular disorders such as ALS, myasthenia gravis, or Lambert-Eaton syndrome may be at increased risk of serious side effects. Patients with ...

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

... patients with dementia-related psychosis. Neuroleptic Malignant syndrome (NMS) is a rare and potentially fatal side effect reported with ... by more than a pre-specified margin. (c) Positive and Negative syndrome Scale (PANSS) is a standard rating scale used in trials to assess ...

FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children

... conditions: closed epiphyses (closed bone growth plates), Prader-Willi syndrome with severe obesity, or Prader-Willi syndrome with significant respiratory impairment. Be sure to tell your doctor if ...

Neurocrine Biosciences Reports Third Quarter 2008 Results

... currently in clinical development for mood disorders and irritable bowel syndrome (IBS). There are currently three distinct CRF compounds in clinical ... markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia ...

Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment

... ability to sleep, as assessed by Visual Analogue Scale (VAS). "Sjogren's syndrome patients are seeking effective relief of their dry mouth. By combining the ... associated with oral dryness caused by Sjogren's syndrome. Sjogren's syndrome is a chronic disorder that occurs when a person's immune system attacks ...

Alexion Reports Third Quarter 2008 Results

... life-threatening and rare hematologic disorders: atypical hemolytic uremic syndrome ("aHUS"), a disease in which the lack of naturally occurring complement ... can cause life-threatening kidney damage; catastrophic anti-phospholipid syndrome ("CAPS"), a disorder in which uncontrollable blood clotting often leads to ...

Lilly to Take Charge to Earnings Related to Pending Federal and State Investigations of Past Practices

... a rare and potentially fatal condition knows as Neuroleptic Malignant syndrome NMS has been reported with Zyprexa. If signs and symptoms appear, ... of treatment and the total cumulative dose of antipsychotic increase. The syndrome may remit, partially or completely, if antipsychotic treatment is ...

FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania

... fatal symptom complex, sometimes referred to as Neuroleptic Malignant syndrome (NMS), has been reported in association with administration of ... is < 1000/mm.(3) Tardive dyskinesia (TD), a potentially irreversible syndrome of involuntary dyskinetic movements, may develop in patients treated ...

Revealing the regulating mechanism behind signal transduction in the brain

... of protein production. This, in its turn, causes diseases like Fragile X syndrome and Autism. Indeed, CYFIP1 has been recently found associated to Autism. ... that, through its absence, FMRP plays a role in diseases like Fragile X syndrome and Autism. ...

More Evidence Published That Epidemics of Childhood Obesity, Type 2 Diabetes and Metabolic Syndrome are Linked to Immunization

... that epidemics of childhood obesity, type 2 diabetes and metabolic syndrome are the result of exposure to the increasing number of vaccines. Metabolic ... including type 1 diabetes but they are causing an epidemic of metabolic syndrome as the immune system acts to suppress the inflammation and autoimmunity ...

ReceptorBio Announces Diabetes License Agreement With Telik

... of Type 2 diabetes mellitus (T2D) and the Insulin Resistance/Metabolic syndrome (Journal of Biological Chemistry (2002), 277, 43565-43571). "ReceptorBio ... related diseases including obesity, and the insulin resistance/metabolic syndrome which has been associated with a markedly increased risk of cardiovascular ...

Neurocrine Biosciences Reports Second Quarter 2008 Results

... currently in clinical development for mood disorders and irritable bowel syndrome (IBS). There are currently three distinct CRF compounds in clinical ... markets in the world including endometriosis, irritable bowel syndrome (IBS), anxiety, depression, pain, diabetes, benign prostatic hyperplasia ...